DUBLIN–(BUSINESS WIRE)–The “U.S. Weight Loss & Weight-reduction plan Management Market: Business (non-medical) Applications & Merchandise” report from Marketdata LLC has been added to ResearchAndMarkets.com’s providing. The $38 billion U.S. industrial weight reduction market is 15% bigger than in 2020, however has needed to pivot to regulate to very large competitors from the favored GLP-1 medication. The massive industrial chains have been harm essentially the most since 2022. Business weight reduction companies misplaced $2 billion in gross sales to the GLP-1 drug
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/glp-1-drugs-reshape-u-s-weight-loss-industry-2-billion-shift-from-commercial-firms-researchandmarkets-com/
